Tag Archives | DNA

Genentech extends buyback program by $2 billion

Genentech (NYSE: DNA) announced a $2 billion extension of its current $6 billion stock repurchase program that is authorized through June 2008. The board kept the program limited to a total of 100 million shares, of which, the company had completed the repurchase of 67 million shares through March 2007. ### PAYOUT YIELD ANALYSIS Because [...]

Read full story Comments are closed